These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7813389)
1. L-acetylcarnitine treatment of mental decline in the elderly. Salvioli G; Neri M Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389 [TBL] [Abstract][Full Text] [Related]
2. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results]. Cipolli C; Chiari G Clin Ter; 1990 Mar; 132(6 Suppl):479-510. PubMed ID: 2140973 [TBL] [Abstract][Full Text] [Related]
3. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia. Campi N; Todeschini GP; Scarzella L Clin Ther; 1990; 12(4):306-14. PubMed ID: 2121359 [TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN; Cummings JL; Katz IR; Mintzer J; Perdomo CA; Schwam EM; Whalen E J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990 [TBL] [Abstract][Full Text] [Related]
5. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine. Passeri M; Iannuccelli M; Ciotti G; Bonati PA; Nolfe G; Cucinotta D Int J Clin Pharmacol Res; 1988; 8(5):367-76. PubMed ID: 3229874 [TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation and mild cognitive impairment: what correlation? Puccio D; Novo G; Baiamonte V; Nuccio A; Fazio G; Corrado E; Coppola G; Muratori I; Vernuccio L; Novo S Minerva Cardioangiol; 2009 Apr; 57(2):143-50. PubMed ID: 19274024 [TBL] [Abstract][Full Text] [Related]
7. Emotional withdrawal, CT abnormalities and drug response in late life depression. Altamura AC; Bassetti R; Santini A; Frisoni GB; Mundo E Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):349-54. PubMed ID: 14751432 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of cholinesterase inhibitors in elderly subjects with Alzheimer's disease: a "real world" study. Mossello E; Tonon E; Caleri V; Tilli S; Cantini C; Cavallini MC; Bencini F; Mecacci R; Marini M; Bardelli F; Sarcone E; Razzi E; Biagini CA; Masotti G Arch Gerontol Geriatr Suppl; 2004; (9):297-307. PubMed ID: 15207427 [TBL] [Abstract][Full Text] [Related]
9. [An experimental, randomized, double-blind, placebo-controlled clinical trial to infestigate the effect of nicardipine on cognitive function in patients with vascular dementia. Spanish group of nicardipine study in vascular dementia]. Rev Neurol; 1999 May 1-15; 28(9):835-45. PubMed ID: 10390744 [TBL] [Abstract][Full Text] [Related]
10. Effect of acetyl-L-carnitine on geriatric patients suffering from dysthymic disorders. Bella R; Biondi R; Raffaele R; Pennisi G Int J Clin Pharmacol Res; 1990; 10(6):355-60. PubMed ID: 2099360 [TBL] [Abstract][Full Text] [Related]
11. Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue. Malaguarnera M; Gargante MP; Cristaldi E; Colonna V; Messano M; Koverech A; Neri S; Vacante M; Cammalleri L; Motta M Arch Gerontol Geriatr; 2008; 46(2):181-90. PubMed ID: 17658628 [TBL] [Abstract][Full Text] [Related]
12. [Methodology of a clinical controlled study of L-acetylcarnitine]. Neri M; Cortelloni C; De Vreese L Clin Ter; 1990 Mar; 132(6 Suppl):457-68. PubMed ID: 2140970 [TBL] [Abstract][Full Text] [Related]
13. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552 [TBL] [Abstract][Full Text] [Related]
14. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Bonavita E Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):511-6. PubMed ID: 3781687 [TBL] [Abstract][Full Text] [Related]
15. Role of acetyl-L-carnitine in the treatment of cognitive deficit in chronic alcoholism. Tempesta E; Troncon R; Janiri L; Colusso L; Riscica P; Saraceni G; Gesmundo E; Calvani M; Benedetti N; Pola P Int J Clin Pharmacol Res; 1990; 10(1-2):101-7. PubMed ID: 2201652 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence]. Daléry J; Aubin V Encephale; 2001; 27(1):71-81. PubMed ID: 11294041 [TBL] [Abstract][Full Text] [Related]
17. [A follow-up study on a randomized, single-blind control of King's Brain pills in treatment of memory disorder in elderly people with MCI in a Beijing community]. Tian JZ; Zhu AH; Zhong J Zhongguo Zhong Yao Za Zhi; 2003 Oct; 28(10):987-91. PubMed ID: 15620194 [TBL] [Abstract][Full Text] [Related]
18. Selegiline in the treatment of Alzheimer's disease: a long-term randomized placebo-controlled trial. Czech and Slovak Senile Dementia of Alzheimer Type Study Group. Filip V; Kolibás E J Psychiatry Neurosci; 1999 May; 24(3):234-43. PubMed ID: 10354658 [TBL] [Abstract][Full Text] [Related]
19. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic. Brodaty H; Moore CM Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942 [TBL] [Abstract][Full Text] [Related]
20. Neuropsychological changes in demented patients treated with acetyl-L-carnitine. Sinforiani E; Iannuccelli M; Mauri M; Costa A; Merlo P; Bono G; Nappi G Int J Clin Pharmacol Res; 1990; 10(1-2):69-74. PubMed ID: 2387665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]